Viking Global Investors LP Trevi Therapeutics, Inc. Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 3,227,792 shares of TRVI stock, worth $19 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,227,792
Previous 4,400,000
26.64%
Holding current value
$19 Million
Previous $18.7 Million
8.31%
% of portfolio
0.07%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding TRVI
# of Institutions
142Shares Held
85.3MCall Options Held
1.5MPut Options Held
304K-
Nea Management Company, LLC Timonium, MD11.4MShares$66.9 Million6.78% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$60.3 Million4.06% of portfolio
-
Rubric Capital Management LP New York, NY4.54MShares$26.7 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$22.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.49MShares$20.5 Million5.95% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $343M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...